NPI: 1063411767 · PARIS, TX 75460 · Ambulatory Surgical Clinic/Center · NPI assigned 07/15/2005
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 07/15/2005 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43 | $6K |
| 2019 | 292 | $30K |
| 2020 | 1,348 | $107K |
| 2021 | 22,228 | $664K |
| 2022 | 22,720 | $930K |
| 2023 | 19,507 | $1.35M |
| 2024 | 8,326 | $616K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,337 | 10,869 | $1.51M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,021 | 4,730 | $1.13M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,062 | 1,880 | $524K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,391 | 3,151 | $165K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 403 | 397 | $74K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 502 | 221 | $67K |
| 80053 | Comprehensive metabolic panel | 5,526 | 4,949 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,519 | 4,816 | $32K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 673 | 633 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,568 | 1,251 | $18K |
| 81001 | 4,983 | 4,655 | $15K | |
| 71045 | Radiologic examination, chest; single view | 1,506 | 1,367 | $15K |
| 87400 | 479 | 263 | $12K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 166 | 164 | $12K |
| 87802 | 389 | 385 | $10K | |
| 36415 | Collection of venous blood by venipuncture | 7,529 | 6,553 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | 429 | 382 | $5K |
| 87088 | 1,327 | 1,222 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | 141 | 139 | $3K |
| 97597 | 29 | 13 | $3K | |
| 81025 | 164 | 161 | $3K | |
| 87430 | 66 | 66 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 463 | 360 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 39 | 38 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 924 | 805 | $2K |
| 83690 | 471 | 428 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | 229 | 222 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 29 | 25 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 28 | 28 | $1K |
| 83880 | 368 | 346 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 55 | 51 | $982.13 |
| 84484 | 1,483 | 932 | $748.49 | |
| 85027 | 1,103 | 959 | $697.63 | |
| J7050 | Infusion, normal saline solution, 250 cc | 644 | 477 | $475.87 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 31 | 31 | $465.94 |
| 87070 | 26 | 26 | $430.02 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 205 | 202 | $354.81 |
| 87186 | 392 | 363 | $277.35 | |
| 85610 | 713 | 661 | $266.57 | |
| 84443 | Thyroid stimulating hormone (TSH) | 413 | 404 | $230.87 |
| 80306 | 31 | 26 | $183.76 | |
| 85730 | 315 | 296 | $180.17 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 761 | 597 | $165.23 |
| 80061 | Lipid panel | 486 | 484 | $159.60 |
| J7030 | Infusion, normal saline solution , 1000 cc | 261 | 212 | $95.07 |
| J2704 | Injection, propofol, 10 mg | 129 | 117 | $83.76 |
| 83735 | 206 | 180 | $79.20 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 25 | 24 | $68.39 |
| J1170 | Injection, hydromorphone, up to 4 mg | 207 | 114 | $56.75 |
| 83036 | Hemoglobin; glycosylated (A1C) | 343 | 334 | $42.30 |
| 85007 | 34 | 29 | $36.66 | |
| 81003 | 19 | 17 | $30.50 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 28 | 24 | $27.83 |
| 86901 | 25 | 24 | $25.83 | |
| 86900 | 26 | 25 | $25.83 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 31 | 27 | $20.86 |
| 83605 | 15 | 12 | $15.85 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 18 | 13 | $15.31 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 19 | 12 | $12.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 56 | 52 | $9.24 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 36 | 33 | $5.88 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 31 | 28 | $5.18 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 12 | 12 | $3.78 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 54 | 44 | $2.52 |
| A9270 | Non-covered item or service | 10,072 | 5,035 | $1.77 |
| 82962 | 339 | 149 | $0.00 | |
| J3490 | Unclassified drugs | 59 | 40 | $0.00 |